SPIN4
geneOn this page
Also known as FLJ44984TDRD28
Summary
SPIN4 (spindlin family member 4, HGNC:27040) is a protein-coding gene on chromosome Xq11.1, encoding Spindlin-4 (Q56A73). Binds to acetylated and methylated histones, including H3K4me3 and H4K20me3, probably acting as a histone reader that recognizes chromatin marks and mediates downstream cellular effects.
Enables methylated histone binding activity. Involved in negative regulation of cell population proliferation and positive regulation of canonical Wnt signaling pathway. Located in chromatin; cytoplasm; and nucleus.
Source: NCBI Gene 139886 — RefSeq curated summary.
At a glance
- Gene–disease (curated): Lui-Jee-Baron syndrome (Moderate, GenCC)
- Clinical variants (ClinVar): 12 total — 1 pathogenic
- Phenotypes (HPO): 15
- Druggable target: yes
- MANE Select transcript:
NM_001012968
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27040 |
| Approved symbol | SPIN4 |
| Name | spindlin family member 4 |
| Location | Xq11.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ44984, TDRD28 |
| Ensembl gene | ENSG00000186767 |
| Ensembl biotype | protein_coding |
| OMIM | 301113 |
| Entrez | 139886 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000374884
RefSeq mRNA: 1 — MANE Select: NM_001012968
NM_001012968
CCDS: CCDS43964
Canonical transcript exons
ENST00000374884 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001465015 | 63347228 | 63351332 |
Expression profiles
Bgee: expression breadth ubiquitous, 236 present calls, max score 96.59.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.8884 / max 209.7798, expressed in 1638 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199442 | 12.9414 | 1586 |
| 199443 | 1.1905 | 698 |
| 199441 | 0.3709 | 206 |
| 199440 | 0.3304 | 177 |
| 199439 | 0.0552 | 15 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 96.59 | silver quality |
| esophagus squamous epithelium | UBERON:0006920 | 92.53 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 88.74 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 87.64 | gold quality |
| visceral pleura | UBERON:0002401 | 87.58 | gold quality |
| gingival epithelium | UBERON:0001949 | 87.42 | gold quality |
| gingiva | UBERON:0001828 | 85.68 | gold quality |
| oral cavity | UBERON:0000167 | 85.44 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 84.83 | gold quality |
| oviduct epithelium | UBERON:0004804 | 84.58 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 84.17 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 83.98 | gold quality |
| mammary duct | UBERON:0001765 | 83.93 | gold quality |
| ventricular zone | UBERON:0003053 | 82.88 | gold quality |
| parietal pleura | UBERON:0002400 | 82.70 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.50 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 82.18 | gold quality |
| bone marrow | UBERON:0002371 | 81.09 | gold quality |
| lower lobe of lung | UBERON:0008949 | 80.78 | gold quality |
| colonic mucosa | UBERON:0000317 | 80.71 | gold quality |
| tibia | UBERON:0000979 | 80.51 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 79.95 | gold quality |
| endometrium | UBERON:0001295 | 79.37 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 78.42 | gold quality |
| amniotic fluid | UBERON:0000173 | 78.30 | gold quality |
| ileal mucosa | UBERON:0000331 | 78.14 | gold quality |
| placenta | UBERON:0001987 | 78.09 | gold quality |
| mammary gland | UBERON:0001911 | 78.05 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 78.00 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 77.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
137 targeting SPIN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spinb | ENSDARG00000035697 |
| danio_rerio | spina | ENSDARG00000058949 |
| mus_musculus | Spin4 | ENSMUSG00000071722 |
| rattus_norvegicus | Spin4 | ENSRNOG00000077287 |
Paralogs (4): SPIN1 (ENSG00000106723), SPIN2A (ENSG00000147059), SPIN2B (ENSG00000186787), SPIN3 (ENSG00000204271)
Protein
Protein identifiers
Spindlin-4 — Q56A73 (reviewed: Q56A73)
All UniProt accessions (1): Q56A73
UniProt curated annotations — full annotation on UniProt →
Function. Binds to acetylated and methylated histones, including H3K4me3 and H4K20me3, probably acting as a histone reader that recognizes chromatin marks and mediates downstream cellular effects. Promotes canonical WNT signaling, and is involved in the down-regulation of cell proliferation.
Subunit / interactions. Interacts with C11orf84/SPINDOC. Associates with chromatin.
Subcellular location. Cytoplasm. Nucleus.
Disease relevance. Lui-Jee-Baron syndrome (LJBS) [MIM:301114] An X-linked disorder characterized by prenatal onset, generalized overgrowth, extreme tall stature, enlarged liver and spleen, macrocephaly, dysmorphic features, and normal development. Hemizygous males are more severely affected than heterozygous females. The disease may be caused by variants affecting the gene represented in this entry. A variant causing frameshift and truncation of the SPIN4 protein has been found in one family with Lui-Jee-Baron syndrome. In mice, SPIN4 truncating mutations result in features recapitulating the human disease, including generalized overgrowth and increased longitudinal bone growth. Growth plate analysis of mutant mice reveales increased cell proliferation in the proliferative zone and an increased number of progenitor chondrocytes in the resting zone.
Similarity. Belongs to the SPIN/STSY family.
RefSeq proteins (1): NP_001012986* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003671 | SPIN/Ssty | Family |
| IPR042567 | SPIN/Ssty_sf | Homologous_superfamily |
Pfam: PF02513
UniProt features (29 total): strand 16, region of interest 5, turn 2, helix 2, site 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4UY4 | X-RAY DIFFRACTION | 1.86 |
| 9T31 | X-RAY DIFFRACTION | 2.04 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q56A73-F1 | 82.17 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 159 (histone h3k4me3 and h3r8me2a binding); 170 (histone h3k4me3 and h3r8me2a binding)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 152 (showing top):
GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY, GOBP_CANONICAL_WNT_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY, GRADE_COLON_AND_RECTAL_CANCER_DN, VERNELL_RETINOBLASTOMA_PATHWAY_UP, KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3, GEORGES_TARGETS_OF_MIR192_AND_MIR215, VECCHI_GASTRIC_CANCER_EARLY_UP, WHITFIELD_CELL_CYCLE_G1_S, CHICAS_RB1_TARGETS_SENESCENT, CHICAS_RB1_TARGETS_GROWING, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN, chrXq11
GO Biological Process (5): regulation of DNA-templated transcription (GO:0006355), gamete generation (GO:0007276), negative regulation of cell population proliferation (GO:0008285), positive regulation of canonical Wnt signaling pathway (GO:0090263), chromatin organization (GO:0006325)
GO Molecular Function (2): histone H3K4me3 reader activity (GO:0140002), protein binding (GO:0005515)
GO Cellular Component (5): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| sexual reproduction | 1 |
| multicellular organismal reproductive process | 1 |
| cell population proliferation | 1 |
| regulation of cell population proliferation | 1 |
| negative regulation of cellular process | 1 |
| positive regulation of Wnt signaling pathway | 1 |
| canonical Wnt signaling pathway | 1 |
| regulation of canonical Wnt signaling pathway | 1 |
| cellular component organization | 1 |
| histone H3 reader activity | 1 |
| binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
288 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPIN4 | ARHGEF9 | O43307 | 512 |
| SPIN4 | GMCL1 | Q96IK5 | 506 |
| SPIN4 | HP1BP3 | Q5SSJ5 | 466 |
| SPIN4 | ATOSB | Q7L5A3 | 438 |
| SPIN4 | TAF13 | Q15543 | 435 |
| SPIN4 | SPINDOC | Q9BUA3 | 400 |
| SPIN4 | C2CD5 | Q86YS7 | 385 |
| SPIN4 | MAGEA10 | P43363 | 383 |
| SPIN4 | CAPN6 | Q9Y6Q1 | 382 |
| SPIN4 | ALG13 | Q9NP73 | 379 |
| SPIN4 | C10orf71 | Q711Q0 | 377 |
| SPIN4 | HEPH | Q9BQS7 | 372 |
| SPIN4 | EDA2R | Q9HAV5 | 372 |
| SPIN4 | KCTD3 | Q9Y597 | 364 |
| SPIN4 | ADAM20 | O43506 | 360 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPIN1 | PAX3 | psi-mi:“MI:0914”(association) | 0.530 |
| SPIN4 | PRMT6 | psi-mi:“MI:0914”(association) | 0.530 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| SPIN4 | FBXO11 | psi-mi:“MI:0914”(association) | 0.350 |
| PRTN3 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.350 |
| SPIN4 | MBL2 | psi-mi:“MI:0914”(association) | 0.350 |
| SPIN4 | DIS3L2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (20): SPIN4 (Affinity Capture-RNA), SPIN4 (Affinity Capture-RNA), SPIN4 (Affinity Capture-MS), SPIN4 (Affinity Capture-MS), SPIN4 (Affinity Capture-MS), SPIN4 (Affinity Capture-MS), DCAF16 (Affinity Capture-MS), PRMT6 (Affinity Capture-MS), PKLR (Affinity Capture-MS), TPK1 (Affinity Capture-MS), MBL2 (Affinity Capture-MS), SPIN1 (Affinity Capture-MS), FBXO11 (Affinity Capture-MS), DCAF16 (Affinity Capture-Western), SPIN4 (Affinity Capture-Western)
ESM2 similar proteins: B3H754, C6KIE6, F4I8W1, F4ISV9, F4J4N3, F4K3G5, F4K487, K7TQE3, O22267, O23610, O80568, P13675, P59178, Q0WS06, Q32N90, Q500V5, Q56A73, Q683D5, Q6AUQ7, Q6DBH0, Q6NKN8, Q84WJ0, Q8K1L2, Q8RXM6, Q94HV8, Q969R5, Q9C5P0, Q9C5Q9, Q9C7I9, Q9C8N7, Q9C8N9, Q9FFA0, Q9FGS8, Q9FJX8, Q9FJX9, Q9FMV0, Q9FT92, Q9FV02, Q9FX25, Q9LG02
Diamond homologs: P13675, Q2KI39, Q4V8J7, Q56A73, Q5JUX0, Q5R997, Q5RA80, Q5RAW7, Q61142, Q6NVE3, Q8K1L2, Q90WG1, Q90WG2, Q99865, Q9BPZ2, Q9Y657
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
12 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2671851 | NM_001012968.3(SPIN4):c.312_313del (p.Arg104fs) | Pathogenic |
SpliceAI
88 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:63351164:G:C | donor_gain | 0.9900 |
| X:63351163:A:AC | donor_gain | 0.9800 |
| X:63351163:AG:A | donor_gain | 0.9600 |
| X:63350144:TCGCC:T | donor_gain | 0.9500 |
| X:63350124:A:AC | donor_gain | 0.9000 |
| X:63350180:TGG:T | donor_gain | 0.8600 |
| X:63350125:A:C | donor_gain | 0.8300 |
| X:63350805:G:T | acceptor_gain | 0.8300 |
| X:63348491:C:G | acceptor_gain | 0.8100 |
| X:63350143:TTCGC:T | donor_gain | 0.7500 |
| X:63350150:C:CT | donor_gain | 0.7400 |
| X:63350204:C:CT | donor_gain | 0.7200 |
| X:63350205:C:CT | donor_gain | 0.7000 |
| X:63350203:TC:T | donor_gain | 0.6900 |
| X:63350147:C:CT | donor_gain | 0.6800 |
| X:63351164:G:A | donor_gain | 0.6400 |
| X:63350178:CTTGG:C | donor_gain | 0.6200 |
| X:63350729:T:TA | acceptor_gain | 0.5800 |
| X:63351157:C:CT | donor_gain | 0.5800 |
| X:63348492:T:TG | acceptor_gain | 0.5200 |
| X:63350151:C:CT | donor_gain | 0.5100 |
| X:63351158:C:CT | donor_gain | 0.5000 |
| X:63350807:T:TC | acceptor_gain | 0.4700 |
| X:63350788:ACCCC:A | acceptor_gain | 0.4400 |
| X:63350789:CCCCC:C | acceptor_gain | 0.4400 |
| X:63351159:A:AC | donor_gain | 0.4400 |
| X:63351160:C:CC | donor_gain | 0.4400 |
| X:63350804:CGGT:C | acceptor_gain | 0.4300 |
| X:63351160:CTTAG:C | donor_gain | 0.4300 |
| X:63350994:CTA:C | donor_gain | 0.4100 |
AlphaMissense
1633 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:63350439:A:C | F127L | 0.999 |
| X:63350439:A:T | F127L | 0.999 |
| X:63350441:A:G | F127L | 0.999 |
| X:63350118:A:C | F234L | 0.998 |
| X:63350118:A:T | F234L | 0.998 |
| X:63350120:A:G | F234L | 0.998 |
| X:63350293:A:G | L176S | 0.998 |
| X:63350364:A:C | F152L | 0.998 |
| X:63350364:A:T | F152L | 0.998 |
| X:63350366:A:G | F152L | 0.998 |
| X:63350673:C:A | W49C | 0.997 |
| X:63350673:C:G | W49C | 0.997 |
| X:63350440:A:C | F127C | 0.996 |
| X:63350588:A:G | Y78H | 0.996 |
| X:63350589:T:A | K77N | 0.996 |
| X:63350589:T:G | K77N | 0.996 |
| X:63350639:C:G | G61R | 0.996 |
| X:63350119:A:G | F234S | 0.995 |
| X:63350311:T:A | D170V | 0.995 |
| X:63350335:A:T | L162H | 0.995 |
| X:63350354:A:G | Y156H | 0.995 |
| X:63350398:A:T | V141D | 0.995 |
| X:63350405:C:G | G139R | 0.995 |
| X:63350440:A:G | F127S | 0.995 |
| X:63350591:T:C | K77E | 0.995 |
| X:63350629:A:T | L64H | 0.995 |
| X:63350686:A:C | I45S | 0.995 |
| X:63350686:A:G | I45T | 0.995 |
| X:63350686:A:T | I45N | 0.995 |
| X:63350121:C:A | K233N | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1053713 (X:63347590 T>C), RS111287985 (X:63347451 T>C), RS111923761 (X:63348588 G>T), RS113579085 (X:63352061 A>G), RS1156493888 (X:63352627 G>A,T), RS1156688942 (X:63351563 C>T), RS1158595894 (X:63348004 C>G,T), RS1158691165 (X:63347395 T>C), RS1159270746 (X:63353257 G>T), RS1159434178 (X:63346735 C>T), RS1159506306 (X:63352037 T>A,C), RS1159634932 (X:63349401 TAAA>T,TA,TAA), RS1159704013 (X:63351198 G>A), RS1160115370 (X:63351580 G>C,T), RS1160307389 (X:63350220 G>A)
Disease associations
OMIM: gene MIM:301113 | disease phenotypes: MIM:301114
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| Lui-Jee-Baron syndrome | Moderate | X-linked |
Mondo (1): Lui-Jee-Baron syndrome (MONDO:0957919)
Orphanet (0):
HPO phenotypes
15 total (15 of 15 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000256 | Macrocephaly |
| HP:0000411 | Protruding ear |
| HP:0000490 | Deeply set eye |
| HP:0000494 | Downslanted palpebral fissures |
| HP:0001249 | Intellectual disability |
| HP:0001417 | X-linked inheritance |
| HP:0001520 | Large for gestational age |
| HP:0001548 | Overgrowth |
| HP:0001744 | Splenomegaly |
| HP:0001763 | Pes planus |
| HP:0002002 | Deep philtrum |
| HP:0002240 | Hepatomegaly |
| HP:0002343 | Normal pressure hydrocephalus |
| HP:0003577 | Congenital onset |
| HP:0006610 | Wide intermamillary distance |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523321 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
3 potent at pChembl≥5 of 3 total, top 3 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.74 | Kd | 18.1 | nM | CHEMBL4451634 |
| 6.77 | Kd | 170 | nM | CHEMBL4552020 |
| 6.15 | Kd | 710 | nM | CHEMBL5594627 |
PubChem BioAssay actives
3 with measured affinity, of 5 total; 3 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 2-[4-[2-[[2-[3-[2-amino-5-(cyclopropylmethoxy)-3,3-dimethylindol-6-yl]oxypropyl]-1,3-dihydroisoindol-5-yl]oxy]ethyl]triazol-1-yl]-1-[4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]ethanone | 1526487: Binding affinity to recombinant human His-tagged SPIN4 (36 to 249 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry | kd | 0.0181 | uM |
| [3-(aminomethyl)-5-[3-(1,3-dihydroisoindol-2-yl)propoxy]-4-methoxyphenyl]methanamine | 1578937: Inhibition of recombinant human N-terminal His6-tagged SPIN4 (36 to 249 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as dissociation constant by isothermal titration calorimetry | kd | 0.1700 | uM |
| N-[7-[3-(1,3-dihydroisoindol-2-yl)propoxy]-6-methoxy-4-pyrrolidin-1-ylquinazolin-2-yl]-N’,N’-dimethylethane-1,2-diamine | 2103453: Binding affinity to human N-terminal His6 tagged SPIN4 (T36 to P249 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry | kd | 0.7100 | uM |
CTD chemical–gene interactions
56 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 5 |
| Valproic Acid | affects expression, decreases expression, increases expression | 4 |
| bisphenol A | affects expression, decreases expression | 2 |
| trichostatin A | affects cotreatment, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 2 |
| Endosulfan | decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| testosterone undecanoate | affects cotreatment, decreases expression | 1 |
| mono-(2-ethylhexyl)phthalate | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| resorcinol | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
ChEMBL screening assays
4 unique, capped per target: 4 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4323087 | Binding | Binding affinity to recombinant human His-tagged SPIN4 (36 to 249 residues) expressed in Escherichia coli BL21 (DE3) assessed as melting temperature at 20 uM by Sypro orange dye based differential scanning fluorimetry | A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: Lui-Jee-Baron syndrome
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Lui-Jee-Baron syndrome